Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
about
Serotonin, neural markers, and memorySerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disordermRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brainSerotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors.A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity.Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2.5-hydroxytryptamine 2C receptors tonically augment synaptic currents in the nucleus tractus solitariiLikelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS).Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in ratsMeasuring endogenous 5-HT release by emission tomography: promises and pitfalls.Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.Serotonin2C receptors and drug addiction: focus on cocaine.Genetic factors in exercise adoption, adherence and obesity.The vital role of constitutive GPCR activity in the mesolimbic dopamine system.Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.New insights on the antidepressant discontinuation syndrome.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.Atypical antipsychotics and inverse agonism at 5-HT2 receptors.Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal CortexExpression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum.Chronic spinal cord injury causes upregulation of serotonin (5-HT)2A and 5-HT2C receptors in lumbosacral cord motoneurons.Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice.5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders.
P2860
Q26800204-76DA5945-B0AB-4051-994B-D79A9DE0070EQ27015917-B816451F-6C53-43D6-9015-7D773E6A31E4Q30578745-D6C0F887-74A9-4902-A60E-A8640C90CD5EQ34033693-3ACA26B3-A717-46F4-8D5E-555C114C60ADQ34145991-FE271B1A-C46A-4C52-96A7-B1524439C7E8Q34187552-A60D6ECB-7649-42E0-B321-62CBF7B4AE30Q34206821-293B2262-5431-4E12-A84C-042B24852946Q34236107-20D52FA2-1907-48A8-8F82-77F3AE5B3719Q34686451-58B32135-0088-4AD3-8E99-C623A553BC87Q36512082-428E75F8-496E-4709-B3E0-07551027E3C5Q36532612-92C4E30B-8F9F-49FC-B357-AE3865539B06Q36806137-D438D72E-0F67-4EF5-96D3-37382B1DF1EEQ37308265-199DC43F-9ADC-4A5D-8B8C-7E6142308194Q37416428-B712F90C-B173-4F94-90E2-84CB4416BB1CQ37776154-675BB5B1-0081-4EAE-8374-7BCFB8F4C16BQ37834732-192676C0-2E04-483A-B634-7A558BDD205EQ38113111-C6E367E6-E4E9-4F7C-9393-82CBD757D274Q38137370-AB3B4B4D-C565-4248-9282-1670A55AE22CQ38187259-27279640-4F7C-4F4A-B136-D7702835B225Q38203915-B9C03204-8779-4A79-9F6A-0F084CC7268EQ38238790-6FF52A1A-C91C-4718-B395-48F87E92E88EQ39164871-9D00AD78-8FA7-40D1-B897-01530659DA87Q39696405-D1F13AE8-D79B-47D4-B8C3-6AD914CDDA3DQ40571585-A4EC58DF-D6D4-4FEF-945F-D2033D29C98EQ41250110-8072C8B2-F075-42CE-B236-4A98E46F4EE2Q42369139-217744D5-5489-4413-9EFE-EAA7904899D6Q42494096-506D520F-4031-4E6F-867A-1D3916B49083Q47273224-BC797997-7105-4CD6-81B8-E8E920B4F39EQ47330880-ABE8B82B-E6BF-4920-A445-7DDEC2E04CE9Q47357220-E4009B56-D1E1-4A5C-AD71-3D3A25F884AEQ53417297-AF11DAA1-83C0-4D5F-9E57-360F46BE625F
P2860
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
@en
Current status of inverse agonism at serotonin2A
@nl
type
label
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
@en
Current status of inverse agonism at serotonin2A
@nl
prefLabel
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
@en
Current status of inverse agonism at serotonin2A
@nl
P2093
P1476
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
@en
P2093
J A Harvey
U Spampinato
W P Clarke
P304
P356
10.1016/J.PHARMTHERA.2008.10.010
P577
2008-12-06T00:00:00Z